info@pdci.ca
Newsletter Sign-Up
Login to PDCI Services
Contact Us
Navigation
Home
About Us
What We Do
Develop Effective P&R Strategies
Establish Optimal Pricing
Demonstrate Value
Achieve Timely Market Access
Our Team
Careers
Services
Case Studies
News & Events
Resources
Provincial & CDR Deadlines
Common Drug Review (CDR) Submission Deadlines and CDEC Meeting Dates
PMPRB
PMPRB CPI Adjustment Factors Allowable Price Increases
PMPRB HDAP Meeting Dates & Submission Deadlines
Links
Consultation Responses
Blog
Publications
What’s New
Home
What’s New
11
Jul
2023
PMPRB Launches Consultation on its Amendment to the Interim Guidance RE: New Medicines
July 11, 2023
On June 20, 2023, PMPRB published proposed amendments to the Interim Guidance relating to New Medicines. PMPRB has ...
Read More
02
May
2023
PDCI’s Webinar Series: Tips for Health Technology Assessment (HTA) Submissions: Plan your Trip, Pack your Bags and Leave on Time
May 2, 2023
Join us on May 31st @ 12 p.m. ET for our upcoming webinar entitled: Tips for Health Technology ...
Read More
01
May
2023
Connect with PDCI Market Access at the CADTH Symposium in Ottawa, May 16-18, 2023
May 1, 2023
PDCI Market Access is proud to announce is participation as a Platinum Sponsor of the 2023 CADTH Symposium ...
Read More
23
Mar
2023
Federal Government Allocates Up to $1.4 Billion to Improve Access to Drugs for Rare Diseases
March 23, 2023
On March 22, 2023, Federal Minister of Health Jean-Yves Duclos announced $1.5 billion in funding associated with the ...
Read More
Previous
1
2
3
4
5
6
7
...
96
Next